Fig 6. TA treatment and co-treatment of TA with a sub-therapeutic antibiotic treatment provides significant protection against lethal pulmonary melioidosis.

BALB/c mice (n = 5 per group) were infected with 2 X 10³ CFU (~3 X LD50) of B. pseudomallei 1026b intranasal. Three hours post-infection treatments were administered, then again daily for two consecutive days totaling three treatments. Survival was monitored for 37 days. Statistical significance was determined via the Mantel-Cox test. **p<0.01, ****p<0.0001.